Bob Dagher

Direttore Tecnico/Scientifico/R&S presso BRAINSTORM CELL THERAPEUTICS INC.

Patrimonio netto: 134 596 $ in data 30/04/2024

55 anni

Health Technology

Consumer Services

Posizioni attive di Bob Dagher

Società	Posizione	Inizio	Fine
BRAINSTORM CELL THERAPEUTICS INC.	Direttore Tecnico/Scientifico/R&S	16/04/2024	-
BRAINSTORM CELL THERAPEUTICS INC.	Corporate Officer/Principal	17/07/2023	16/04/2024

Società	Posizione	Inizio	Fine
ENVERIC BIOSCIENCES, INC.	Direttore Tecnico/Scientifico/R&S	06/12/2021	01/01/2023
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/12/2019	01/12/2021
COVANCE INC.	Direttore Tecnico/Scientifico/R&S	01/01/2018	01/01/2019
MedAvante-ProPhase, Inc.	Direttore Tecnico/Scientifico/R&S	-	-

Faculté De Médecine Necker Enfants Malades Université	Undergraduate Degree
Université de Bordeaux	Undergraduate Degree

Distribuzione geografica

Stati Uniti	6
Francia	3

Posizioni

Chief Tech/Sci/R&D Officer	4
Corporate Officer/Principal	2
Undergraduate Degree	2

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
ENVERIC BIOSCIENCES, INC.	Health Technology
BRAINSTORM CELL THERAPEUTICS INC.	Health Technology

Aziende private	3
MedAvante-ProPhase, Inc.
Labcorp Drug Development, Inc. Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ.	Health Technology
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Health Technology